In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine Drug Master File in Korea (3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine. The MFDS reviews the 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine KDMF as part of the drug registration process and uses the information provided in the 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine KDMF to evaluate the safety and efficacy of the drug.
After submitting a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine suppliers with KDMF on PharmaCompass.